When to Start Anti-HIV Drugs in Patients With Opportunistic Infections

Completed · Phase 4

Conditions studied: HIV Infections, AIDS-Related Opportunistic Infections

In brief

The purpose of this study is to evaluate the effect of starting anti-HIV drugs in HIV infected patients who are being treated for opportunistic infections (OIs). This study will follow two patient groups: those who received anti-HIV drugs soon after being diagnosed with an OI and patients with OIs who deferred beginning anti-HIV drugs until after recovering from the OI.

Key facts

Study ID
NCT00055120
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
People needed
283
Starts
2003-03-01
Expected to finish
2007-08-01
Last updated by the study team
2014-10-15

Who can join

Age: 13 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.